Skip to main content

Table 1 Patients’ characteristics

From: Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer

  1. NAC Neoadjuvant chemotherapy, BMI Body mass index, ECOG PS Eastern Cooperative Oncology Group Performance Status, Ce Cervical esophagus, Ut Upper thoracic esophagus, Mt Middle thoracic esophagus, Lt Lower thoracic esophagus, Ae Abdominal esophagus, CF Cisplatin plus 5-Fluorouracil, DCF Docetaxel cisplatin plus 5-Fluorouracil, CRT(CF) Concurrent chemoradiotherapy with cisplatin plus 5-Fluorouracil
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us